GI Dynamics® Inc., a medical device company that is developing the EndoBarrier® System for patients diagnosed with type 2 diabetes and obesity, is pleased...
Clinical trial results presented at the Institute for Healthcare Improvement (IHI) Forum show that virtual multidisciplinary care for gastrointestinal (GI) disorders from Oshi Health resulted in significantly higher...
First prospective study of its kind conducted in primary care settings, shows remarkable diagnostic performance: 95% sensitivity and 86% specificity, outperforming primary care physicians...
THERACLION has announced the results of the first SONOVEIN® trial in the United States, a major milestone towards receiving FDA approval and accessing the...
Conformal Medical, Inc. announced the presentation of the one-year data from the company's initial left atrial appendage occlusion (LAAO) cases with its novel CLAAS® System...
Vista.ai, a pioneer and leader in automated MRI solutions, announced results from a clinical adaptation study on the company's One Click MRI™ software, led...
System Designed to Reduce the Incidence of Positive Margins – or Cancer Left Behind - After Breast Cancer Surgery
CairnSurgical, Inc., an innovator striving to...
Varian, a Siemens Healthineers company, has announced that the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) for the pivotal...
Lipogems, a clinical stage- global medical technology company, announces the first patient enrolled on January 13, 2023, in the ARISE U.S. FDA IDE study, which...